| 2022 | Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2022 | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
| GUT AND LIVER |
| 2022 | Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation | DISEASES OF THE COLON & RECTUM |
| 2022 | Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer
| CANCERS |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence
| GUT AND LIVER |
| 2022 | Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study
| DIAGNOSTICS |
| 2022 | Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases
| SCIENTIFIC REPORTS |
| 2022 | Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment
| BMC GASTROENTEROLOGY |
| 2022 | Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
| BMJ OPEN GASTROENTEROLOGY |
| 2022 | Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
| GUT AND LIVER |
| 2022 | Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms
| ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL |
| 2021 | Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2021 | C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease
| BMC GASTROENTEROLOGY |
| 2021 | An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways | FREE RADICAL BIOLOGY AND MEDICINE |
| 2021 | Behçet syndrome | NATURE REVIEWS DISEASE PRIMERS |
| 2021 | Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
| GUT AND LIVER |
| 2021 | Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
| THERAPEUTIC ADVANCES IN CHRONIC DISEASE |
| 2021 | Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK) | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and Effectiveness | ADVANCES IN THERAPY |
| 2021 | A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state
| CELL REPORTS |
| 2021 | Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
| THERAPEUTIC ADVANCES IN GASTROENTEROLOGY |
| 2021 | Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
| INTESTINAL RESEARCH |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2021 | Physical activity and quality of life of patients with inflammatory bowel disease
| MEDICINE |
| 2021 | Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease
| SCIENTIFIC REPORTS |
| 2021 | The Influence of Disease Activity on Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis | JOURNAL OF CROHNS & COLITIS |
| 2021 | The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis | CANCER PREVENTION RESEARCH |
| 2021 | Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations
| HUMAN MOLECULAR GENETICS |
| 2021 | MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases
| PLOS ONE |
| 2021 | IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor | MOLECULAR CARCINOGENESIS |
| 2021 | Microbiome analysis reveals that Ralstonia is responsible for decreased renal function in patients with ulcerative colitis
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2021 | Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177 + Neutrophils
| FRONTIERS IN IMMUNOLOGY |
| 2021 | Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2021 | Incidence and Prevalence of Inflammatory Bowel Disease across Asia
| YONSEI MEDICAL JOURNAL |
| 2021 | Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation
| FRONTIERS IN IMMUNOLOGY |
| 2021 | Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn's Disease: Results from the CONNECT Study
| JOURNAL OF CLINICAL MEDICINE |
| 2021 | Effect of Thiopurine on Potential Surgical Intervention in Crohn’s Disease in Korea: Results from the CONNECT Study
| JOURNAL OF CLINICAL MEDICINE |
| 2021 | Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn's Disease
| GUT AND LIVER |
| 2021 | Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet's disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
| BMC GASTROENTEROLOGY |
| 2021 | Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
| Journal of Rheumatic Diseases |
| 2020 | Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction | JOURNAL OF INFECTION |
| 2020 | Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis
| YONSEI MEDICAL JOURNAL |
| 2020 | Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
| CANCERS |
| 2020 | Impact of early anti-TNF use on clinical outcomes in Crohn's disease: a nationwide population-based study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
http://orcid.org/0000-0002-2282-8904
(35200350500)
